GB/T 43279.2-2023
ActiveMolecular in vitro diagnostic examinations—Specifications for pre-examination processes for venous whole blood—Part 2:Isolated genomic DNA
分子体外诊断检验 静脉全血检验前过程的规范 第2部分：分离基因组DNA
Application Summary AI generated
This standard specifies the pre-examination processes for isolating genomic DNA from venous whole blood used in molecular in vitro diagnostic testing. It is applied in clinical laboratories and healthcare settings to ensure the quality, integrity, and traceability of DNA samples before analysis, covering steps such as collection, transport, storage, and DNA extraction. The standard is critical for accurate downstream molecular diagnostics, including genetic testing, disease screening, and personalized medicine.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 136-2026
Medical laboratories—Reagents for staining biological specimen—Guidance for users
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.